Inferra AI / Company / DVA
DaVita
DVA · Health Care
Last earnings Oct 29, 2026
Key results
Consolidated revenuequarter
$3.420 billion
Financial and operating highlights for the quarter ended September 30, 2025 Consolidated revenues were $3.420 billion.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Operating incomequarter
$506 million
Operating income was $506 million and adjusted operating income was $517 million.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Adjusted operating incomequarter
$517 million
Operating income was $506 million and adjusted operating income was $517 million.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
EPSquarter
$2.04
Diluted earnings per share was $2.04 and adjusted diluted earnings per share was $2.51.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Adjusted EPSquarter
$2.51
Diluted earnings per share was $2.04 and adjusted diluted earnings per share was $2.51.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Free cash flowquarter
$604 million
Operating cash flow was $842 million and free cash flow was $604 million.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Diluted net incomequarter
$ 2.04
Basic net income $ 2.09 $ 2.56 $ 6.77 $ 7.86 Diluted net income $ 2.04 $ 2.50 $ 6.62 $ 7.66 Weighted average shares for earnings per share Basic shares 72,075 83,721 75,768 86,123 Diluted shares 73,769 85,795 77,442 88,422 6 DAVITA INC.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Operating marginquarter
14.8 %
Consolidated business metrics Operating margin 14.8 % 15.9 % 14.8 % Adjusted operating margin excluding certain items (2) 15.1 % 16.3 % 15.0 % General and administrative expenses as a percent of consolidated revenues (1) 12.1 % 12.2 % 12.0 % Effective income tax rate on income 22.2 % 25.4 % 22.4 % Effective income tax rate on income attributable to DaVita Inc.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Adjusted operating marginquarter
15.1 %
Consolidated business metrics Operating margin 14.8 % 15.9 % 14.8 % Adjusted operating margin excluding certain items (2) 15.1 % 16.3 % 15.0 % General and administrative expenses as a percent of consolidated revenues (1) 12.1 % 12.2 % 12.0 % Effective income tax rate on income 22.2 % 25.4 % 22.4 % Effective income tax rate on income attributable to DaVita Inc.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Revenuequarter
12.1 %
Consolidated business metrics Operating margin 14.8 % 15.9 % 14.8 % Adjusted operating margin excluding certain items (2) 15.1 % 16.3 % 15.0 % General and administrative expenses as a percent of consolidated revenues (1) 12.1 % 12.2 % 12.0 % Effective income tax rate on income 22.2 % 25.4 % 22.4 % Effective income tax rate on income attributable to DaVita Inc.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Capexquarter
$ 996
Cash flow Operating cash flow $ 842 $ 324 $ 1,346 Operating cash flow, last twelve months $ 1,893 $ 1,862 Free cash flow (2) $ 604 $ 157 $ 716 Free cash flow, last twelve months (2) $ 996 $ 947 Capital expenditures Maintenance $ 119 $ 90 $ 304 Development $ 47 $ 32 $ 126 Acquisition expenditures $ 108 $ $ 118 Proceeds from sale of self-developed properties $ 8 $ 12 $ 29 6.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Other International Total Consolidated Operating income (loss) $ 530 $ (21) $ (4) $ 27 $ 1 $ (26) $ 506 Cybersecurity incident-related charges (1) 12 12 Adjusted operating income (loss) $ 542 $ (21) $ (4) $ 27 $ 1 $ (26) $ 517 Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
AI analysis
Q3 2025 · reported Oct 29, 2025
Based on: Earnings release + parent 8-K — transcript not held
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Consolidated revenue | $3.420 billion | $3.380 billion | — |
| Operating income | $506 million | $538 million | — |
| Adjusted operating income | $517 million | $538 million | — |
| EPS | $2.04 | $2.58 | — |
| Adjusted EPS | $2.51 | $2.58 | — |
| Free cash flow | $604 million | $157 million | — |
| Diluted net income | $ 2.04 | $ 2.58 | — |
| Operating margin | 14.8 % | 15.9 % | — |
Guidance · company-stated
No guidance located in the held release
Margin
Cash flow & capex
Capital allocation
Refinanced existing Term Loan B-1 with a new $1.9 billion Term Loan B-2.
Repurchased 3.3 million shares of the Company's common stock at an average price paid of $140.67 per share.
Event summary
(NYSE DVA) announced financial and operating results for the quarter ended September 30, 2025
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
Refinanced existing Term Loan B-1 with a new $1.9 billion Term Loan B-2.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Repurchased 3.3 million shares of the Company's common stock at an average price paid of $140.67 per share.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
In July 2025, we entered into the Seventh Amendment to our senior secured credit agreement to refinance our existing Term Loan B-1 facility maturing May 9, 2031 with a repriced Term Loan B-2 facility in aggregate principal amount of $1.9 billion, which includes the incremental borrowing of Tranche B-2 term loans of $250 million.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
We used the proceeds from the new Term Loan B-2 facility to pay off the remaining principal balance outstanding and accrued interest and fees on our prior Term Loan B-1 in the amount of $1.6 billion and to repay a portion of the principal balance then outstanding on our Term Loan A-1 facility in the amount of $250 million.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
During the three months ended September 30, 2025, we repurchased 3.3 million shares for $465 million, at an average price paid of $140.67 per share.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Effective August 21, 2025, the Board increased the authorization under our existing share repurchase program by $2.0 billion in additional repurchasing authority.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Strategy & priorities
Our consistent focus on providing outstanding care is the key to these results, enabling us to continuously invest in improving the lives of our patients and supporting our dedicated teammates and physician partners.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Risks & headwinds
Outlook The following forward-looking measures and the underlying assumptions involve significant known and unknown risks and uncertainties, including those described below, and actual results may vary materially from these forward-looking measures.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
As a result, our estimates of our patients under, and the dollar amount of, our value-based contracts remain subject to estimation uncertainty.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
What changed vs prior quarter
Consolidated revenue — prior quarter passage and this quarter's passage are both cited.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Operating income — prior quarter passage and this quarter's passage are both cited.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
EPS — prior quarter passage and this quarter's passage are both cited.
SEC original ↗DaVita — Earnings release (8-K exhibit)EX-99Oct 29, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documents- Q3 2026
- 8-KDVA
Oct 29, 2026
- Q2 2026
- 10-QDVA
Aug 4, 2026
- 8-KDVA
Aug 4, 2026
- Q1 2026
- 8-KDVA
Jun 8, 2026
- 10-QDVA
May 5, 2026
- 8-KDVA
May 5, 2026
- Q4 2025
- 10-KDVA
Feb 11, 2026
- 8-KDVA
Feb 2, 2026
- Q3 2025
- 8-KDVA
Nov 25, 2025
- 10-QDVA
Oct 29, 2025
- 8-KDVA
Oct 29, 2025
- Q2 2025
- 8-KDVA
Aug 20, 2025
- 10-QDVA
Aug 5, 2025
- 8-KDVA
Aug 5, 2025
- 8-KDVA
Jul 17, 2025
- Q1 2025
- 8-KDVA
Jun 9, 2025
- 8-KDVA
May 23, 2025
- 8-KDVA
May 20, 2025
- 8-KDVA
May 20, 2025
- 10-QDVA
May 12, 2025
- 8-KDVA
May 12, 2025
- 8-KDVA
Apr 14, 2025
- Q4 2024
- 10-KDVA
Feb 13, 2025
- 8-KDVA
Feb 13, 2025
- Q3 2024
- 10-QDVA
Oct 29, 2024
- 8-KDVA
Oct 29, 2024
- Q2 2024
- 8-KDVA
Sep 13, 2024
- 8-KDVA
Sep 5, 2024
- 8-KDVA
Aug 14, 2024
- 8-KDVA
Aug 9, 2024
- 8-KDVA
Aug 8, 2024
Earnings releases
9 documentsPresentations
0 documentsNo presentations for DaVita are held in this edition of the library.
Transcripts
0 documentsNo transcripts for DaVita are held in this edition of the library.
Mentioned by
10 companiesOther tracked companies whose held documents mention DaVita by name or ticker. A mention is counted once per document, from the document text the library holds.
“ommon dividends 7 As provided in the capital rules, excludes AOCI on cash flow hedges and DVA related to structured notes 8 Primarily CET1 capital deductions 9 Reflects Loans and… …impact of employee issuances. Excludes excise tax and commissions 8 L”
“ommon dividends 8 As provided in the capital rules, excludes AOCI on cash flow hedges and DVA related to structured notes 9 Primarily CET1 capital deductions 10 Includes Loans and… …Standardized CET1 capital ratio of 14.5%2; Advanced CET1 capital rat”
“ons… …Inc. $ 265,397 $ 199,337 $ 462,927 $ 362,254 Earnings per share attributable to DaVita Inc.: Basic net income $ 4.10 $ 2.62 $ 7.01 $ 4.67 Diluted net income $ 4.02 $ 2.58 $ 6.86 $ 4.57 Weighted… …2,027 Free cash flow (1) $ 256”
“ in common stock repurchases) • Book value per common share rose 7% to $39.34; tangible… …DVA(E) From Chair and CEO Brian Moynihan: The team delivered one of our strongest quarters to date, with earnings per share up 34% year-over-year. Every busines”
“ compliance with complex, and at times, evolving government regulations… …attributable to DaVita Inc. $ 197,530 $ 162,917 Earnings per share attributable to DaVita Inc.: Basic net income $ 2.93 $ 2.05 Diluted net income $ 2.87 $ 2.00 ”
“ges… …Inc. $ 234,217 $ 259,329 $ 746,803 $ 936,342 Earnings per share attributable to DaVita Inc.: Basic net income from continuing operations $ 3.00 $ 3.18 $ 9.72 $ 11.02 Basic net income $ 3.36 $ 3.18… …1,893 Free cash flow (1) $ 309 $ 60”
“ges… …Inc. $ 150,332 $ 214,688 $ 512,586 $ 677,013 Earnings per share attributable to DaVita Inc.: Basic net income $ 2.09 $ 2.56 $ 6.77 $ 7.86 Diluted net income $ 2.04 $ 2.50 $ 6.62 $ 7.66 Weighted… …1,862 Free cash flow (2) $ 604”
“ose 7% to $38.66; tangible … …Commodities (FICC) revenue up 2% to $3.5 billion. Excl. net DVA, up 1%(E) From Chair and CEO Brian Moynihan: Earnings per share rose 25% year-over-year, starting 2026 with strong momentum. Net income of $8.6 billion refl”
“ommon dividends 7 As provided in the capital rules, excludes AOCI on cash flow hedges and DVA related to structured notes 8 Primarily CET1 capital deductions 9 Includes Loans and… …commissions 7 Last twelve months (“LTM”) Balance sheet Capital distri”
“4 24 0.02 4.2 Exit of business (7) — (26) 0.3 37 0.5 37 37 0.03 — … …agreement with DaVita Inc. (7) The charges relate to the exit of a business and are primarily comprised of inventory write-downs. (8) The charge primarily relates to a $764 mi”
See also the earnings calendar for every tracked company’s next earnings date.